Narodowy Instytut Onkologii Im Marii Sklodowskiej Curie W Warszawie

Warsaw 02-781

3 studies enrolling now · 5 studies all time

What they study most

Advanced Malignancies, B-cell Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia, Gastroesophageal Junction Adenocarcinoma, Marginal Zone Lymphoma, Metastatic Gastric Adenocarcinoma, Refractory Cancer, Relapsed Cancer, Relapsed/Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed